INS and Hyperglycemia: However, intraperitoneal injection with STZ selectively kills insulin-producing cells in the pancreas and leads to rapid hyperglycaemia with blood glucose levels reaching 20–25 mmol l−1 within 7 days (Extended Data Fig. 10b, red highlighted area).